IL10 and adult T-cell leukemia/lymphoma: Further studies have shown that after HTLV-1-infected cells secrete IL-10, it can inhibit host immune responses through paracrine pathways while simultaneously supporting the proliferation of ATLL cells through autocrine pathways, achieving a dual effect [146–148].